As of 2024-12-11, the Relative Valuation of Arcutis Biotherapeutics Inc (ARQT) is (38.80) USD. This relative valuation is based on P/E multiples. With the latest stock price at 13.15 USD, the upside of Arcutis Biotherapeutics Inc based on Relative Valuation is -395.1%.
The range of the Relative Valuation is (36.29) - (33.85) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.7x - 31.7x | 26.7x |
| Forward P/E multiples | 19.2x - 20.3x | 19.8x |
| Fair Price | (36.29) - (33.85) | (38.80) |
| Upside | -375.9% - -357.4% | -395.1% |
| Date | P/E |
| 2024-12-10 | -7.87 |
| 2024-12-09 | -7.53 |
| 2024-12-06 | -7.42 |
| 2024-12-05 | -7.37 |
| 2024-12-04 | -7.55 |
| 2024-12-03 | -7.34 |
| 2024-12-02 | -7.43 |
| 2024-11-29 | -7.81 |
| 2024-11-27 | -7.01 |
| 2024-11-26 | -6.89 |
| 2024-11-25 | -6.45 |
| 2024-11-22 | -6.07 |
| 2024-11-21 | -6.13 |
| 2024-11-20 | -6.09 |
| 2024-11-19 | -6.04 |
| 2024-11-18 | -5.64 |
| 2024-11-15 | -5.54 |
| 2024-11-14 | -5.94 |
| 2024-11-13 | -6.27 |
| 2024-11-12 | -6.14 |
| 2024-11-11 | -6.49 |
| 2024-11-08 | -6.48 |
| 2024-11-07 | -6.23 |
| 2024-11-06 | -5.78 |
| 2024-11-05 | -5.57 |
| 2024-11-04 | -5.22 |
| 2024-11-01 | -5.19 |
| 2024-10-31 | -4.97 |
| 2024-10-30 | -5.10 |
| 2024-10-29 | -5.12 |
| 2024-10-28 | -5.21 |
| 2024-10-25 | -5.24 |
| 2024-10-24 | -5.03 |
| 2024-10-23 | -5.00 |
| 2024-10-22 | -4.99 |
| 2024-10-21 | -4.97 |
| 2024-10-18 | -5.22 |
| 2024-10-17 | -5.68 |
| 2024-10-16 | -5.82 |
| 2024-10-15 | -5.60 |
| 2024-10-14 | -5.83 |
| 2024-10-11 | -5.86 |
| 2024-10-10 | -5.85 |
| 2024-10-09 | -5.87 |
| 2024-10-08 | -5.79 |
| 2024-10-07 | -5.86 |
| 2024-10-04 | -6.00 |
| 2024-10-03 | -6.09 |
| 2024-10-02 | -6.12 |
| 2024-10-01 | -5.72 |